More Articles Back to Article
Sanofi, GSK COVID-19 vaccine being reviewed in Europe
The European Medicines Agency has begun a rolling review of Sanofi and GlaxoSmithKline's COVID-19 vaccine, to "assess the compliance of Vidprevtyn with the usual EU standards for effectiveness, safety and quality," the regulator said. The drugmakers hope to have the vaccine approved by the end of this year. Reuters (7/20)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!